Six-Year Incidence of Proteinuria in Type 1 Diabetic African Americans
- Monique S. Roy, MD1,
- Mahmoud Affouf, PHD2 and
- Alec Roy, MD3
- 1Institute of Ophthalmology and Visual Science, New Jersey Medical School, University of Medicine and Dentistry (UMDNJ), Newark, New Jersey
- 2Department of Mathematics, Kean University, Union, New Jersey
- 3East Orange Veterans Affairs Medical Center, East Orange, New Jersey
- Address correspondence and reprint requests to Monique S. Roy, MD, UMDNJ-New Jersey Medical School, Department of Ophthalmology, 90 Bergen St., Room 6164, Newark, NJ 07101-1709. E-mail: roymo{at}umdnj.edu
Abstract
OBJECTIVE— We sought to report the 6-year incidence of proteinuria and associated risk factors in African Americans with type 1 diabetes.
RESEARCH DESIGN AND METHODS— African Americans (n = 483) with type 1 diabetes were reexamined in a 6-year follow-up study. Proteinuria and creatinuria were measured in 4-h timed urine specimens obtained at initial and follow-up visits. Other evaluations included a structured clinical interview, ocular examination, masked grading of seven stereoscopic fundus photographs, blood pressure measurements, blood assays, and administration of the Beck Depression Inventory (BDI).
RESULTS— Over the 6-year period, 117 (42.9%) of the 473 patients at risk developed “any” proteinuria, defined as either microalbuminuria (26.0%) or overt (16.9%) proteinuria; 87 (23.5%) progressed from micro- or no albuminuria to overt proteinuria and 39 (8.7%) to end-stage renal disease; and 40 (20.6%) regressed. Peak incidence of any proteinuria occurred for patients who were 10–14 years of age or had 5–10 years of diabetes duration at baseline. Multiple regression analysis showed that baseline albumin excretion rate (AER), systemic hypertension, blood cholesterol, and high BDI depression scores were significant and independent risk factors for incidence of any proteinuria.
CONCLUSIONS— In African Americans with type 1 diabetes, the 6-year incidence of proteinuria is high, particularly among young patients and those with a relatively short duration of diabetes at baseline. Baseline AER is the strongest predictor for incidence of any proteinuria.
Footnotes
-
Published ahead of print at http://care.diabetesjournals.org on 2 May 2007. DOI: 10.2337/dc06-2534.
Additional information for this article can be viewed in an online appendix at http://dx.doi.org/10.2337/dc06-2534.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
-
- Accepted April 17, 2007.
- Received December 28, 2006.
- DIABETES CARE














